Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

United States Platelet Rich Plasma Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The United States platelet rich plasma market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to continue its strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Platelet-rich plasma (PRP) refers to a concentrated plasma protein that contains minor quantities of red blood cells. The platelets are suspended in a small amount of plasma after centrifugation and stimulate healing when injected into the body. PRP is widely administered by non-invasive therapies for long-lasting rejuvenation of ligaments and muscle fibers. Some of the common variants of PRP include pure platelet-rich plasma (P-PRP), leukocyte- and platelet-rich plasma (LPRP), leukocyte- and platelet-rich Fibrin (L-PRF), and pure platelet-rich fibrin (P-PRF).

The rising prevalence of chronic tendon injuries in vital organs is currently bolstering the demand for PRP-based therapies in the US. Furthermore, increasing adoption of effective therapies for treating muscle and acute ligament tearing, arthritis, fractures, orthopedic impairments, etc., is also propelling the market growth. In line with this, the growing awareness towards numerous benefits of PRP treatment in preventing inflammation, encouraging new cartilage formulation, and inducing natural lubrication fluid production, is further augmenting the product demand in the country. Moreover, the rising deployment of advanced healthcare facilities for sports clubs and teams is also catalyzing the adoption of PRP-based therapies for treating common injuries in athletes, such as lumbar spine disc pain, rotator cuff injuries, shoulder pain and instability, tennis/golfer’s elbow, etc. Apart from this, the expanding cosmetic surgery sector in the United States is further driving the utilization of PRP-based procedures for improving facial shape and volume. In the coming years, the increasing healthcare expenditures along with the rising demand for non-invasive medical procedures will continue to spur the demand for PRP-based therapies in the United States.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the United States platelet rich plasma market, along with forecasts at the country and regional level from 2021-2026. Our report has categorized the market based on product type, origin, application and end user.

Breakup by Product Type:

  • Pure Platelet-Rich Plasma (P-PRP)
  • Leukocyte- and Platelet-Rich Plasma (LPRP)
  • Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • Pure Platelet-Rich Fibrin (P-PRF)
     

Breakup by Origin:

  • Autologous PRP
  • Homologous PRP
  • Allogeneic PRP
     

Breakup by Application:

  • Orthopedics
  • Cosmetic Surgery and Dermatology
  • Neurosurgery
  • General Surgery
  • Cardiothoracic Surgery
  • Urology
  • Ophthalmology
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Research Institutes
  • Others
     

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product Type, Origin, Application, End User, Region
Region Covered Northeast, Midwest, South, West
Companies Covered Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option

Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the United States platelet rich plasma market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the United States platelet rich plasma market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the origin?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the United States platelet rich plasma market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    United States Platelet Rich Plasma Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Pure Platelet-Rich Plasma (P-PRP)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Leukocyte- and Platelet-Rich Plasma (LPRP)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Leukocyte- and Platelet-Rich Fibrin (L-PRF) 
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Pure Platelet-Rich Fibrin (P-PRF)
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Origin
    7.1    Autologous PRP
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Homologous PRP
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Allogeneic PRP
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Orthopedics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cosmetic Surgery and Dermatology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Neurosurgery
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    General Surgery
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Cardiothoracic Surgery
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Urology
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Ophthalmology
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Research Institutes 
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1 Northeast
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Midwest
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.3 South
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 West
        10.4.1 Market Trends
        10.4.2 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 SWOT Analysis
        15.3.2    Arthrex Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
        15.3.3    Depuy Synthes Inc. (Johnson & Johnson)
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials
        15.3.4    Dr Prp USA LLC
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
        15.3.5    EmCyte Corporation
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
        15.3.6    Exactech Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
        15.3.7    Glofinn America LLC (Glofinn Co. Ltd.)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
        15.3.8    Regen Lab USA LLC
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
        15.3.9    Stryker Corporation
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Terumo BCT Inc. (Terumo Corporation)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    ThermoGenesis Holdings Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Zimmer Biomet Holdings Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio 
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: United States: Platelet Rich Plasma Market: Major Drivers and Challenges
Figure 2: United States: Platelet Rich Plasma Market: Sales Value (in Million US$), 2015-2020
Figure 3: United States: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: United States: Platelet Rich Plasma Market: Breakup by Product Type (in %), 2020
Figure 5: United States: Platelet Rich Plasma Market: Breakup by Origin (in %), 2020
Figure 6: United States: Platelet Rich Plasma Market: Breakup by Application (in %), 2020
Figure 7: United States: Platelet Rich Plasma Market: Breakup by End User (in %), 2020
Figure 8: United States: Platelet Rich Plasma Market: Breakup by Region (in %), 2020
Figure 9: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: United States: Platelet Rich Plasma (Autologous PRP) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: United States: Platelet Rich Plasma (Autologous PRP) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: United States: Platelet Rich Plasma (Homologous PRP) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: United States: Platelet Rich Plasma (Homologous PRP) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: United States: Platelet Rich Plasma (Allogeneic PRP) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: United States: Platelet Rich Plasma (Allogeneic PRP) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: United States: Platelet Rich Plasma (Orthopedics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: United States: Platelet Rich Plasma (Orthopedics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: United States: Platelet Rich Plasma (Neurosurgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: United States: Platelet Rich Plasma (Neurosurgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: United States: Platelet Rich Plasma (General Surgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: United States: Platelet Rich Plasma (General Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: United States: Platelet Rich Plasma (Urology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: United States: Platelet Rich Plasma (Urology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: United States: Platelet Rich Plasma (Ophthalmology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: United States: Platelet Rich Plasma (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: United States: Platelet Rich Plasma (Other Application) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: United States: Platelet Rich Plasma (Other Application) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: United States: Platelet Rich Plasma (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: United States: Platelet Rich Plasma (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United States: Platelet Rich Plasma (Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United States: Platelet Rich Plasma (Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: United States: Platelet Rich Plasma (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: United States: Platelet Rich Plasma (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Northeast: Platelet Rich Plasma Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Northeast: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Midwest: Platelet Rich Plasma Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Midwest: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: South: Platelet Rich Plasma Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: South: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: West: Platelet Rich Plasma Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: West: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: United States: Platelet Rich Plasma Industry: SWOT Analysis
Figure 54: United States: Platelet Rich Plasma Industry: Value Chain Analysis
Figure 55: United States: Platelet Rich Plasma Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: United States: Platelet Rich Plasma Market: Key Industry Highlights, 2020 and 2026
Table 2: United States: Platelet Rich Plasma Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: United States: Platelet Rich Plasma Market Forecast: Breakup by Origin (in Million US$), 2021-2026
Table 4: United States: Platelet Rich Plasma Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: United States: Platelet Rich Plasma Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: United States: Platelet Rich Plasma Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: United States: Platelet Rich Plasma Market: Competitive Structure
Table 8: United States: Platelet Rich Plasma Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links